Neogenomics, Inc.
NEO
$7.42
$0.294.07%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 358.08M | 386.84M | 387.81M | 387.86M | 384.83M |
Total Receivables | 152.31M | 150.64M | 152.83M | 148.08M | 142.12M |
Inventory | 29.77M | 26.75M | 24.46M | 23.21M | 20.32M |
Prepaid Expenses | 22.98M | 20.17M | 18.24M | 17.40M | 19.16M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 10.79M | 11.62M | 6.91M | 7.66M | 7.48M |
Total Current Assets | 573.93M | 596.02M | 590.24M | 584.20M | 573.90M |
|
|||||
Total Current Assets | 573.93M | 596.02M | 590.24M | 584.20M | 573.90M |
Net Property, Plant & Equipment | 167.41M | 173.69M | 174.48M | 175.83M | 174.44M |
Long-term Investments | 522.77M | 522.77M | 522.77M | 522.77M | 522.77M |
Goodwill | 522.77M | 522.77M | 522.77M | 522.77M | 522.77M |
Total Other Intangibles | 331.32M | 339.68M | 348.04M | 356.40M | 364.76M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 6.01M | 5.89M | 5.58M | 4.08M | 4.47M |
Total Assets | 1.60B | 1.64B | 1.64B | 1.64B | 1.64B |
|
|||||
Total Accounts Payable | 16.21M | 21.61M | 16.51M | 17.19M | 18.34M |
Total Accrued Expenses | 58.12M | 75.07M | 75.16M | 68.15M | 52.74M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 204.21M | 204.16M | 204.14M | 203.65M | 4.49M |
Total Finance Division Other Current Liabilities | 1.16M | 409.00K | 589.00K | 972.00K | 1.14M |
Total Other Current Liabilities | 1.16M | 409.00K | 589.00K | 972.00K | 1.14M |
Total Current Liabilities | 279.70M | 301.24M | 296.41M | 289.96M | 76.71M |
|
|||||
Total Current Liabilities | 279.70M | 301.24M | 296.41M | 289.96M | 76.71M |
Long-Term Debt | 340.71M | 340.34M | 339.96M | 339.58M | 538.92M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 59.86M | 60.84M | 62.17M | 63.29M | 64.77M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 32.89M | 33.28M | 34.37M | 34.56M | 36.52M |
Total Liabilities | 713.16M | 735.70M | 732.90M | 727.39M | 716.93M |
|
|||||
Common Stock & APIC | 1.24B | 1.23B | 1.22B | 1.21B | 1.20B |
Retained Earnings | -351.70M | -325.78M | -310.46M | -292.76M | -274.12M |
Treasury Stock & Other | -56.00K | -206.00K | -643.00K | -1.02M | -1.33M |
Total Common Equity | 888.27M | 902.34M | 908.21M | 915.88M | 923.41M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 888.27M | 902.34M | 908.21M | 915.88M | 923.41M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 888.27M | 902.34M | 908.21M | 915.88M | 923.41M |
|